Noble Capital Markets Reiterates Outperform Rating on Unicycive Therapeutics, Inc. (UNCY)

Market Context

Unicycive Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $5.28 with a market capitalization of $113.3M.

Analyst coverage from Noble Capital Markets provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Unicycive Therapeutics, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Unicycive Therapeutics, Inc.

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 01, 2026	Benchmark	Speculative Buy	N/A
Jul 01, 2026	Noble Capital Markets	Outperform	N/A
Jun 30, 2026	B. Riley Securities	Buy	N/A
Jun 30, 2026	HC Wainwright & Co.	Buy	N/A
Jun 02, 2026	Benchmark	Speculative Buy	N/A

Related Tools: Analyst Ratings Dashboard | View UNCY Stock Page